CorMedix (CRMD)

CorMedix (CRMD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CRMD last traded at $5.70, -25.46% on the day.
• CorMedix: market cap $443.89M, P/E 2.3, revenue $462.25M over the last four quarters, next earnings 2026-11-11.
• Over the past year CRMD returned -50.99%; year to date -51.03%.

Updated 2026-11-02 17:50 UTC